Diabetes drug found no better than placebo at treating nonalcoholic fatty liver disease
Thursday, May 12, 2016 - 20:00
in Health & Medicine
A diabetes medication described in some studies as an effective treatment for nonalcoholic fatty liver disease (NAFLD) works no better than a placebo, report researchers after conducting the first randomized, double-blind, controlled clinical trial of sitagliptin, an oral antihyperglycemic marketed under the name Januvia.